Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis-Reference-Cited by-同舟云学术

Elexacaftor-Tezacaftor- Ivacaftor improves sinonasal outcomes in cystic fibrosis

Published:2022-09 Issue:5 Volume:21 Page:792-799
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Stapleton Amanda L.,Kimple Adam J.,Goralski Jennifer L.,Nouraie S. Mehdi,Branstetter Barton F,Shaffer Amber D,Pilewski Joseph M,Senior Brent A,Lee Stella E,Zemke Anna C.

Funder

National Institutes of Health

NHLBI

Cystic Fibrosis Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference32 articles.

1. Patterns of sinusitis in cystic fibrosis;Gentile;Laryngoscope,1996

2. Nasal endoscopy and paranasal sinus computerised tomography (CT) findings in an Irish cystic fibrosis adult patient group;Casserly;Eur Arch Otorhinolaryngol,2015

3. International consensus statement on allergy and rhinology: allergic rhinitis;Wise;Int Forum Allergy Rhinol,2018

4. Evolution of sinonasal clinical features in children with cystic fibrosis;Suy;Int J Pediatr Otorhinolaryngol,2019

5. Management of sinusitis in the cystic fibrosis patient;Okafor;Immunol Allergy Clin North Am,2020

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional and radiological sinonasal outcomes of CFTR modulators for sinus disease in cystic fibrosis: A meta‐analysis;International Forum of Allergy & Rhinology;2024-08-30

2. Cystic fibrosis-related chronic rhinosinusitis: the key role of a comprehensive evaluation in the era of highly effective modulator therapy;European Archives of Oto-Rhino-Laryngology;2024-08-07

3. Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant;Current Opinion in Pulmonary Medicine;2024-08-01

4. Impact of sociodemographic status and sex on chronic rhinosinusitis and olfaction in people with cystic fibrosis;International Forum of Allergy & Rhinology;2024-07-05

5. Impact of elexacaftor/tezacaftor/ivacaftor CFTR modulator therapy on rates of endoscopic sinus surgery in cystic fibrosis;International Forum of Allergy & Rhinology;2024-07-03